TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy September 20, 1985
TCL Archive In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform May 9, 1997
